| • |
Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages
Hayashi T, Kawashima S, Itoh H, et al, for the Japan CDM Group
Diabetes Care. 2009;32(7):1221-1223 |
| • |
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
The BARI 2D Study Group
N Engl J Med. 2009 Jun 7. [Epub ahead of print] |
| • |
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Ray KK, Seshasai SR, Wijesuriya S, et al
Lancet. 2009;373(9677):1765-1772 |
| • |
Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial
Young LH, Wackers FJ, Chyun DA, et al for the DIAD Investigators
JAMA. 2009;301(15):1547-1555 |
| • |
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction
Goyal A, Mehta SR, Gerstein HC, et al
Am Heart J. 2009;157(4):763-770 |
| • |
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study
Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L
Diabetologia. 2009 Mar 12. [Epub ahead of print] |
| • |
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events
Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, et al, for the GRACE Investigators
Arch Intern Med. 2009;169(4):402-409 |
| • |
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Raz I, Wilson PW, Strojek K, et al
Diabetes Care. 2009;32(3):381-386 |
| • |
The prevention of progression of arterial disease and diabetes (POPADAD) trial
Belch J, MacCuish, Campbell I, et al, for the Prevention of Progression of Arterial Disease and Diabetes Study Group
BMJ. 2008;337:a1840 |
| • |
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM.
ACC Abstracts of the 48th Scientific Session. 298(3):309-16 |
| • |
Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis.
Riche DM, Valderrama R, Henyan NN
Diabetes Care. 2007 Feb ; 30(2): 384-388 |
| • |
Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)
Wilcox R, Bousser MG, Betteridge DJ, et al
Stroke. 2007;38:865-873 |
| • |
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M
Lancet. 2006;368:1651-1659 |
| • |
High-dose atorvastatin after stroke or transient ischemic attack
Amarenco P, Bogousslavsky J, Callahan A 3rd, et al for the SPARCL Investigators
N Engl J Med. 2006;355:549-559 |
| • |
Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
Bowden DW, Lohman K, Hsu FC, et al
Diabet Med. 2006;23:763-767 |
| • |
Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men
Kurl S, Laukkanen JA, Niskanen L, et al
Stroke. 2006 |
| • |
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Dormandy JA, Charbonnel B, Eckland DJ, et al
Lancet. 2005;366:1279-1289 |
| • |
Stroke prevention in diabetic and other high cardiovascular risk patients
El Atat F, Rundek T, Sowers JR, McFarlane SI
Curr Diab Rep. 2005;5:200-207 |
| • |
Impact of Obesity and the Metabolic Syndrome on Risk Factors in African American Stroke Survivors: A Report From the AAASPS
Ruland S, Hung E, Richardson D, Misra S, Gorelick PB
Arch Neurol. 2005;62:386-390 |
| • |
Epidemiology of ischemic stroke in patients with diabetes: the greater cincinnati/northern kentucky stroke study
Kissela BM, Khoury J, Kleindorfer D, et al.
Diabetes Care. 2005;28:355-359 |
| • |
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
Malik S, Wong ND, Franklin SS
Circulation. 2004;110:1239-1244 |
| • |
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up
Almdal T, Scharling H, Jensen JS, Vestergaard H
Arch Intern Med. 2004;164:1422-1426 |
| • |
Lipid Lowering in Patients With Type 2 Diabetes Lowers Risk of Heart Attack and Stroke, Regardless of Cholesterol Levels: CARDS
|
| • |
Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes
Stevens RJ, Coleman RL, Adler AI, et al
ACC Abstracts of the 48th Scientific Session. 2004;27:201-207 |
| • |
Confirmation from the Framingham Heart Study: Being Overweight Carries Increased Risk for Hypertension, Cardiovascular Disease, Hypercholesterolemia, and Diabetes
|
| • |
Angioplasty Is More Effective Than Thrombolytic Therapy in Diabetic Patients With AMI
Hasdai D, Granger CB, Srivatsa SS, et al.
J Am Coll Cardiol. 2000;35:1502-1512 |
| • |
Prospective Associations of Fasting Insulin, Body Fat Distribution, and Diabetes With Risk of Ischemic Stroke
|
| • |
Increased Common Carotid Artery Intima-Media Thickness Is a Risk Factor for Ischemic Stroke in Patients With Type 2 Diabetes
Matsumoto K, Sera Y, Nakamura H, et al.
Metabolism. 2002;51:244-247 |
